Singular Genomics Systems, Inc. Sustainability Profile
Singular Genomics Systems, Inc., a pioneering force in the genomics industry, is headquartered in the United States. Founded in 2016, the company has rapidly established itself as a leader in next-generation sequencing (NGS) technology, focusing on innovative solutions for genomic research and clinical applications. With a commitment to advancing precision medicine, Singular Genomics offers unique products such as the G4 sequencer, designed to deliver high-throughput, cost-effective sequencing capabilities. This cutting-edge technology sets the company apart by enabling researchers to conduct complex genomic analyses with unprecedented speed and accuracy. Recognised for its significant contributions to the field, Singular Genomics continues to expand its operational reach, positioning itself as a key player in the global genomics landscape.
DitchCarbon Score
How does Singular Genomics Systems, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Singular Genomics Systems, Inc.'s score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Singular Genomics Systems, Inc.'s reported carbon emissions
Singular Genomics Systems, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there are no emissions data or reduction initiatives available, it is unclear how Singular Genomics Systems, Inc. aligns with industry standards for climate action. The absence of information on emissions and climate commitments may reflect a broader trend within the biotechnology sector, where companies are increasingly being called upon to disclose their environmental impact and set ambitious sustainability goals.
How Carbon Intensive is Singular Genomics Systems, Inc.'s Industry?
How Carbon Intensive is Singular Genomics Systems, Inc.'s Location?
Singular Genomics Systems, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Singular Genomics Systems, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
